A copper drug, Cu(ATSM), reduces toxic protein buildup linked to Alzheimer's disease Cu(ATSM) repairs P-glycoprotein pumps, improving brain waste clearance by 24.1 percent The treatment lowers amyloid-beta protein levels by 42 percent in Alzheimer's mouse models